Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 15/20 | 0.62 |
| ▸ | PIK3CG | P48736 | 14/20 | 0.62 |
| ▸ | PIK3R1 | P27986 | 8/20 | 0.62 |
| ▸ | PIK3CA | P42336 | 8/20 | 0.62 |
| ▸ | PIK3CB | P42338 | 7/20 | 0.62 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.62 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.62 |
| ▸ | HTR2A | P28223 | 1/20 | 0.62 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4416181 | 1.00 | PIK3CD (0.62) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL4416177 | 1.00 | PIK3CD (0.62) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL9884258 | 1.00 | PIK3CD (0.62) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL9884376 | 0.95 | PIK3R1 (0.57) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL9924651 | 0.95 | PIK3R1 (0.57) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL9884373 | 0.94 | PIK3R1 (0.57) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL9884375 | 0.94 | PIK3R1 (0.57) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL19725389 | 0.94 | PIK3R1 (0.58) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL9884272 | 0.93 | PIK3R1 (0.60) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL9884310 | 0.93 | PIK3R1 (0.60) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250170122-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | INTELLIKINE LLC (US) | 2025-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250170122-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | PIK3CA, PIK3CG, PIK3CB | PIK3CD 4/4885PIK3CG 2/4885PIK3R1 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.